Search

everythinglearnresearchcommunity

for

Search:↓

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Finasteride helps reduce heart issues and improves heart function.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Women with different PCOS types have similar fertility treatment results.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.